Peripheral Vascular Disease and Peripheral Neuropathy in Individuals With Cardiometabolic Clustering and Obesity
Authors:
Open Access
- 17 June 2011
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 34 (7) , 1642-1647
Abstract
OBJECTIVE: Two lower-extremity diseases (LEDs), including peripheral neuropathy and peripheral vascular disease (PVD), are leading causes of disability in the U.S. Although LEDs can be complications of diabetes, their prevelances and risk factors apart from diabetes are poorly described. This study describes the prevalence of LEDs and examines the association of obesity and cardiometabolic clustering in a population-based sample. RESEARCH DESIGN AND METHODS: Adults aged ≥40 years (n = 2,514) were evaluated in the 2001–2004 National Health and Nutrition Examination Survey for clustering of two or more cardiometabolic characteristics, including elevated triglycerides or plasma glucose, low HDL cholesterol levels, increased waist circumference, or hypertension. Clustering was combined with BMI (dichotomized at ≥30 kg/m2) to generate three groups: obese (with or without clustering); nonobese with clustering; and nonobese without clustering. Multivariate logistic regression procedures incorporated the complex survey sampling design. RESULTS: Overall, 9.0% of individuals had peripheral neuropathy alone, 8.5% had PVD alone, and 2.4% had both LEDs. The obese group was more likely to have peripheral neuropathy (odds ratio 2.20 [95% CI 1.43–3.39]), PVD (3.10 [1.84–5.22]), and both LEDs (6.91 [2.64–18.06]) compared with nonobese subjects without clustering. Within the nonobese group, clustering increased the odds of peripheral neuropathy (1.50 [1.00–2.25]) and PVD (2.48 [1.38–4.44]) compared with no clustering. CONCLUSIONS: Obesity and clustering markedly increased the likelihood of LEDs in this sample and identified a group for whom preventive activities may reduce the risk of future disability.Keywords
This publication has 23 references indexed in Scilit:
- Idiopathic neuropathy patients are at high risk for metabolic syndromeJournal of the Neurological Sciences, 2008
- Mechanisms of disease: The oxidative stress theory of diabetic neuropathyReviews in Endocrine and Metabolic Disorders, 2008
- Neuropathy: mobility and quality of lifeDiabetes/Metabolism Research and Reviews, 2008
- Prevalence of lower extremity diseases associated with normal glucose levels, impaired fasting glucose, and diabetes among U.S. adults aged 40 or olderDiabetes Research and Clinical Practice, 2007
- Diabetic neuropathy and oxidative stressDiabetes/Metabolism Research and Reviews, 2006
- Idiopathic neuropathy, prediabetes and the metabolic syndromeJournal of the Neurological Sciences, 2006
- Small Fiber Neuropathy Is Associated with the Metabolic SyndromeMetabolic Syndrome and Related Disorders, 2005
- Microvascular Complications of Impaired Glucose ToleranceDiabetes, 2003
- Independent effects of peripheral nerve dysfunction on lower-extremity physical function in old age: the Women's Health and Aging Study.Diabetes Care, 2000
- INSULIN AS A VASCULAR HORMONE: IMPLICATIONS FOR THE PATHOPHYSIOLOGY OF CARDIOVASCULAR DISEASEClinical and Experimental Pharmacology and Physiology, 1998